Proteomics profiling for the global and acetylated proteins of papillary thyroid cancers

• Published in: Proteome science Vol. 21; no. 1; p. 6
• Main Authors: Wei, Wei, Wu, Yuezhang, Chen, Dong-Dong, Song, Yuntao, Xu, Guohui, Shi, Qi, Dong, Xiao-Ping
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 26.04.2023; BioMed Central; BMC
• Subjects: Acetylated proteins; Analysis; Bioinformatics; Biomarkers; Carcinogenesis; Carcinoma; Cytoskeleton; Fibronectin; Fibronectins; Histone H2B; Huntingtin; KEGG; Keratin; Malignancy; Mass spectrometry; Ontology; Papillary thyroid cancer; Papillary thyroid carcinoma; Performance evaluation; Polypeptides; Proteins; Proteomics; Reagents; Scientific equipment and supplies industry; Scientific imaging; Thyroglobulin; Thyroid cancer; TMT labeling; Trefoil factor; Tumors; Western blotting; Canada; United States; United States > US; TMT labeling; Acetylated proteins; KEGG; Papillary thyroid cancer; Proteomics
• ISSN: 1477-5956; 1477-5956
• DOI: 10.1186/s12953-023-00207-8

Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy cancer among the malignancies of thyroid. Despite of wide usages of proteomics in PTC, the profile of acetylated proteins in PTC remains unsettled, which is helpful for understanding the carcinogenesis mechanism and identifying useful biomarkers for PTC. The surgically removed specimens of cancer tissues (Ca-T) and adjacent normal tissues (Ca-N) from 10 female patients pathological diagnosed as PTC (TNM stage III) were enrolled in the study. After preparing the pooled extracts of the whole proteins and the acetylated proteins from 10 cases, TMT labeling and LC/MS/MS methods were applied to the assays of global proteomics and acetylated proteomics separately. Bioinformatics analysis, including KEGG, gene ontology (GO) and hierarchical clustering were performed. Some differentially expressed proteins (DEPs) and differentially expressed acetylated proteins (DEAPs) were validated by individual Western blots. Controlled with the normal tissues adjacent to the lesions, 147 out of 1923 identified proteins in tumor tissues were considered as DEPs in global proteomics, including 78 up-regulated and 69 down-regulated ones, while 57 out of 311 identified acetylated proteins in tumor tissues were DEAPs in acetylated proteomics, including 32 up-regulated and 25 down-regulated, respectively. The top 3 up- and down-regulated DEPs were fibronectin 1, KRT1B protein and chitinase-3-like protein 1, as well as keratin, type I cytoskeletal 16, A-gamma globin Osilo variant and Huntingtin interacting protein-1. The top 3 up- and down-regulated DEAPs were ribosomal protein L18a-like protein, alpha-1-acid glycoprotein 2 and eukaryotic peptide chain release factor GTP-binding subunit ERF3A, as well as trefoil factor 3, thyroglobulin and histone H2B. Functional GO annotation and KEGG pathway analysis based on the DEPs and DEAPs showed completely different changing pictures. Contrary to the top 10 up- and -down regulated DEPs, most of which were addressed in PTC and other types of carcinomas, changes of the majority DEAPs were not mentioned in the literatures. Taken the profiling of the global and acetylated proteomics together will provide more broad view of protein alterations on the carcinogenesis and new direction for selecting biomarker for diagnosis of PTC.